Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

PH20 is not expressed in murine CNS and oligodendrocyte precursor cells.

Marella M, Ouyang J, Zombeck J, Zhao C, Huang L, Connor RJ, Phan KB, Jorge MC, Printz MA, Paladini RD, Gelb AB, Huang Z, Frost GI, Sugarman BJ, Steinman L, Wei G, Shepard HM, Maneval DC, Lapinskas PJ.

Ann Clin Transl Neurol. 2017 Feb 23;4(3):191-211. doi: 10.1002/acn3.393. eCollection 2017 Mar.

2.

Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase.

DuFort CC, DelGiorno KE, Carlson MA, Osgood RJ, Zhao C, Huang Z, Thompson CB, Connor RJ, Thanos CD, Scott Brockenbrough J, Provenzano PP, Frost GI, Michael Shepard H, Hingorani SR.

Biophys J. 2016 May 10;110(9):2106-19. doi: 10.1016/j.bpj.2016.03.040.

3.

Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models.

Thompson CB, Shepard HM, O'Connor PM, Kadhim S, Jiang P, Osgood RJ, Bookbinder LH, Li X, Sugarman BJ, Connor RJ, Nadjsombati S, Frost GI.

Mol Cancer Ther. 2010 Nov;9(11):3052-64. doi: 10.1158/1535-7163.MCT-10-0470. Epub 2010 Oct 26.

4.

Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.

Nagabhushan TL, Maneval DC, Benedict WF, Wen SF, Ihnat PM, Engler H, Connor RJ.

Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):389-94. Epub 2007 Aug 9. Review.

PMID:
17692556
5.

Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation.

Tao Z, Connor RJ, Ashoori F, Dinney CP, Munsell M, Philopena JA, Benedict WF.

Cancer Gene Ther. 2006 Feb;13(2):125-30.

PMID:
16082384
6.
7.

Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein.

Benedict WF, Tao Z, Kim CS, Zhang X, Zhou JH, Adam L, McConkey DJ, Papageorgiou A, Munsell M, Philopena J, Engler H, Demers W, Maneval DC, Dinney CP, Connor RJ.

Mol Ther. 2004 Sep;10(3):525-32.

8.

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer.

Yamashita M, Rosser CJ, Zhou JH, Zhang XQ, Connor RJ, Engler H, Maneval DC, Karashima T, Czerniak BA, Dinney CP, Benedict WF.

Cancer Gene Ther. 2002 Aug;9(8):687-91.

9.

Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium.

Connor RJ, Engler H, Machemer T, Philopena JM, Horn MT, Sutjipto S, Maneval DC, Youngster S, Chan TM, Bausch J, McAuliffe JP, Hindsgaul O, Nagabhushan TL.

Gene Ther. 2001 Jan;8(1):41-8.

10.

Investigation of design and bias issues in case-control studies of cancer screening using microsimulation.

Connor RJ, Boer R, Prorok PC, Weed DL.

Am J Epidemiol. 2000 May 15;151(10):991-8.

PMID:
10853638
11.

An analysis of trypanocidal drug use in the Eastern Province of Zambia.

Van den Bossche P, Doran M, Connor RJ.

Acta Trop. 2000 Mar 25;75(2):247-58.

PMID:
10708665
12.

Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents.

Engler H, Anderson SC, Machemer TR, Philopena JM, Connor RJ, Wen SF, Maneval DC.

Urology. 1999 May;53(5):1049-53.

PMID:
10223504
13.

The partial testing design: a less costly way to test equivalence for sensitivity and specificity.

Baker SG, Connor RJ, Kessler LG.

Stat Med. 1998 Oct 15;17(19):2219-32.

PMID:
9802180
14.

Case-control studies of cancer screening: theory and practice.

Cronin KA, Weed DL, Connor RJ, Prorok PC.

J Natl Cancer Inst. 1998 Apr 1;90(7):498-504. Review.

PMID:
9539244
15.
16.

Isometamidium concentrations in the sera of cattle maintained under a chemoprophylactic regime in a tsetse-infested area of Zimbabwe.

Eisler MC, Maruta J, Nqindi J, Connor RJ, Ushewokunze-Obatolu U, Holmes PH, Peregrine AS.

Trop Med Int Health. 1996 Aug;1(4):535-41.

17.
18.

Design and analysis of cancer screening trials.

Etzioni RD, Connor RJ, Porok PC, Self SG.

Stat Methods Med Res. 1995 Mar;4(1):3-17. Review.

PMID:
7613636
19.

Receptor specificity of influenza virus influences severity of illness in ferrets.

Leigh MW, Connor RJ, Kelm S, Baum LG, Paulson JC.

Vaccine. 1995;13(15):1468-73.

PMID:
8578828
20.

The impact of nagana.

Connor RJ.

Onderstepoort J Vet Res. 1994 Dec;61(4):379-83.

PMID:
7501369
21.

Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates.

Connor RJ, Kawaoka Y, Webster RG, Paulson JC.

Virology. 1994 Nov 15;205(1):17-23.

PMID:
7975212
22.

Cek5, a tyrosine kinase of the Eph subclass, is activated during neural retina differentiation.

Pasquale EB, Connor RJ, Rocholl D, Schnürch H, Risau W.

Dev Biol. 1994 Jun;163(2):491-502.

PMID:
7515363
23.

Issues in the mortality analysis of randomized controlled trials of cancer screening.

Connor RJ, Prorok PC.

Control Clin Trials. 1994 Apr;15(2):81-99.

PMID:
8205806
24.

Analysis of the temporal patterns of benefits in the Health Insurance Plan of Greater New York trial by stage and age.

Chu KC, Connor RJ.

Am J Epidemiol. 1991 May 15;133(10):1039-49. Erratum in: Am J Epidemiol 1994 Aug 1;140(3):302.

PMID:
2035504
25.

The case-control design and the assessment of the efficacy of cancer screening.

Connor RJ, Prorok PC, Weed DL.

J Clin Epidemiol. 1991;44(11):1215-21.

PMID:
1941016
26.

Statistical considerations in cancer screening programs.

Prorok PC, Connor RJ, Baker SG.

Urol Clin North Am. 1990 Nov;17(4):699-708.

PMID:
2120836
27.

Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer.

Zurawski VR Jr, Sjovall K, Schoenfeld DA, Broderick SF, Hall P, Bast RC Jr, Eklund G, Mattsson B, Connor RJ, Prorok PC, et al.

Gynecol Oncol. 1990 Mar;36(3):299-305.

PMID:
2318438
28.

Helminthosis in goats in southern Tanzania: investigations on epidemiology and control.

Connor RJ, Munyuku AP, Mackyao E, Halliwell RW.

Trop Anim Health Prod. 1990 Feb;22(1):1-6.

PMID:
2321258
29.

Bovine trypanosomiasis in southern Tanzania: investigation into the incidence of infection and duration of chemoprophylaxis.

Connor RJ, Mukangi DJ, Halliwell RW.

Trop Anim Health Prod. 1989 May;21(2):135-40.

PMID:
2787560
30.

Notes on the routine intravenous use of isometamidium in the control of bovine trypanosomiasis on the Kenya coast.

Dowler ME, Schillinger D, Connor RJ.

Trop Anim Health Prod. 1989 Feb;21(1):4-10.

PMID:
2711462
31.

Stage-shift cancer screening model.

Connor RJ, Chu KC, Smart CR.

J Clin Epidemiol. 1989;42(11):1083-95.

PMID:
2681551
32.

Beware of watered camels.

Waitumbi JN, Connor RJ.

Vet Rec. 1987 Oct 24;121(17):407. No abstract available.

PMID:
3686810
33.

Bovine trypanosomiasis in southern Tanzania: parasitological and serological survey of prevalence.

Connor RJ, Halliwell RW.

Trop Anim Health Prod. 1987 Aug;19(3):165-72.

PMID:
3660451
35.
36.

Concurrent outbreak of pseudo-lumpy skin disease and acute Trypanosoma vivax infection in cattle.

Connor RJ, Mukangi DJ.

Trop Anim Health Prod. 1986 Aug;18(3):127-32.

PMID:
3020750
37.

Screening for the early detection of cancer.

Prorok PC, Connor RJ.

Cancer Invest. 1986;4(3):225-38. Review. No abstract available.

PMID:
3521796
38.

A serological survey of the prevalence of Toxoplasma gondii in goats and sheep in southern Tanzania.

Connor RJ, Halliwell RW.

Ann Trop Med Parasitol. 1985 Feb;79(1):111-2. No abstract available.

PMID:
3985701
39.
40.

Radioimmunoassay for 2-acetylaminofluorene-DNA adducts.

Poirier MC, Connor RJ.

Methods Enzymol. 1982;84:607-18. No abstract available.

PMID:
7098973
41.

Personalizing the porcelain fused to metal restoration.

Connor RJ, Denehy GE.

Quintessence Int Dent Dig. 1981 Sep;12(9):905-13. No abstract available.

PMID:
6945622
42.

Removal of partially loosened fixed partial dentures.

Hall DL, Connor RJ.

J Prosthet Dent. 1981 Feb;45(2):221-3.

PMID:
7009842
43.

A study of immunoregulation of BALB/c mice by Echinococcus granulosus equinus during prolonged infection.

Allan D, Jenkins P, Connor RJ, Dixon JB.

Parasite Immunol. 1981 Summer;3(2):137-42.

PMID:
6972509
44.

Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.

Goldstein K, Lai PK, Lightfoote M, Andrese AP, Fuccillo D, Connor RJ, Levine PH.

Infect Immun. 1980 Sep;29(3):945-52.

45.

Experimental infection of mice with Echinococcus granulosus equinus of British origin.

Connor RJ.

Ann Trop Med Parasitol. 1980 Feb;74(1):97-9. No abstract available.

PMID:
7377878
46.

Equine hydatidosis.

Connor RJ, Hizzard P.

Vet Rec. 1979 May 5;104(18):417. No abstract available.

PMID:
483534
47.

Skin cancer development in mice exposed chronically to immunosuppressive agents.

Daynes RA, Harris CC, Connor RJ, Eichwald EJ.

J Natl Cancer Inst. 1979 Apr;62(4):1075-81.

PMID:
285281
48.
49.

Use of the leukocyte migration inhibition assay to evaluate antigenic differences in human breast cancers and melanomas.

Cannon B, McCoy JL, Connor RJ, Jerome L, Keys L, Dean HH, Herberman RB.

J Natl Cancer Inst. 1978 May;60(5):969-78.

PMID:
76682
50.

Time of appearance and histology of tumors induced in the dorsal skin of C3Hf mice by ultraviolet radiation from a mercury arc lamp.

Spikes JD, Kripke ML, Connor RJ, Eichwald EJ.

J Natl Cancer Inst. 1977 Dec;59(6):1637-43.

PMID:
926187

Supplemental Content

Loading ...
Support Center